Drugs Made In America Acquisition Stock (NASDAQ:DMAA)


OwnershipFinancialsChart

Previous Close

$10.27

52W Range

$9.95 - $10.28

50D Avg

$10.18

200D Avg

$10.11

Market Cap

$344.05M

Avg Vol (3M)

$44.94K

Beta

-0.00

Div Yield

-

DMAA Company Profile


Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

Show More

Industry

Shell Companies

Sector

Financial Services

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

-

Website

DMAA Performance


DMAA Financial Summary


Dec 24
Revenue-
Operating Income$-479.73
Net Income$-479.73
EBITDA-
Basic EPS$-0.06
Diluted EPS$-0.06

Fiscal year ends in Dec 24 | Currency in USD